IL-6 receptor inhibition and risk of sarcoidosis: a Mendelian randomization study.
作者信息
Zhao Sizheng Steven, Baker Matthew C, Galloway James B
机构信息
Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Science, School of Biological Sciences, Faculty of Biological Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Division of Immunology and Rheumatology, Department of Medicine, Stanford University, Stanford, CA, USA.
出版信息
Rheumatology (Oxford). 2024 Apr 2;63(4):e118-e119. doi: 10.1093/rheumatology/kead613.
Abstract
摘要
相似文献
1
IL-6 receptor inhibition and risk of sarcoidosis: a Mendelian randomization study.白细胞介素-6受体抑制与结节病风险：一项孟德尔随机化研究
Rheumatology (Oxford). 2024 Apr 2;63(4):e118-e119. doi: 10.1093/rheumatology/kead613.
2
The causal relationship between sarcoidosis and autoimmune diseases: a bidirectional Mendelian randomization study in FinnGen.结节病与自身免疫性疾病之间的因果关系：芬兰人群中基于双向孟德尔随机化的研究。
Front Immunol. 2024 Apr 22;15:1325127. doi: 10.3389/fimmu.2024.1325127. eCollection 2024.
3
Causal association of inflammatory bowel disease with sarcoidosis and the mediating role of primary biliary cholangitis.炎症性肠病与结节病的因果关联及原发性胆汁性胆管炎的中介作用。
Front Immunol. 2024 Sep 3;15:1448724. doi: 10.3389/fimmu.2024.1448724. eCollection 2024.
4
IL6 receptor inhibitors: exploring the therapeutic potential across multiple diseases through drug target Mendelian randomization.白介素 6 受体抑制剂：通过药物靶点孟德尔随机化探索多种疾病的治疗潜力。
Front Immunol. 2024 Aug 20;15:1452849. doi: 10.3389/fimmu.2024.1452849. eCollection 2024.
5
Exploring the therapeutic potential of interleukin-6 receptor blockade in cardiovascular disease treatment through Mendelian randomization.通过孟德尔随机化探索白细胞介素-6 受体阻断在心血管疾病治疗中的治疗潜力。
Sci Rep. 2024 Sep 13;14(1):21452. doi: 10.1038/s41598-024-72195-4.
6
Inflammatory Biomarkers and Risk of Schizophrenia: A 2-Sample Mendelian Randomization Study.炎症生物标志物与精神分裂症风险：一项两样本孟德尔随机化研究
JAMA Psychiatry. 2017 Dec 1;74(12):1226-1233. doi: 10.1001/jamapsychiatry.2017.3191.
7
Causal relationship of interleukin-6 and its receptor on sarcopenia traits using mendelian randomization.采用孟德尔随机化方法研究白细胞介素-6 及其受体与肌肉减少症特征的因果关系。
Nutr J. 2024 May 15;23(1):51. doi: 10.1186/s12937-024-00958-w.
8
Pathway-Based Mendelian Randomization for Pre-Infection IL-6 Levels Highlights Its Role in Coronavirus Disease.基于通路的孟德尔随机化分析提示感染前白细胞介素 6 水平在冠状病毒病中的作用
Genes (Basel). 2024 Jul 6;15(7):889. doi: 10.3390/genes15070889.
9
The effects of immunomodulatory drugs on cerebral small vessel disease: A mediation Mendelian randomization analysis.免疫调节药物对脑小血管病的影响：中介孟德尔随机分析。
Int Immunopharmacol. 2024 Oct 25;140:112786. doi: 10.1016/j.intimp.2024.112786. Epub 2024 Aug 9.
10
Genetic susceptibility to acne vulgaris increases breast cancer risk: insights from Mendelian randomization.寻常痤疮的遗传易感性增加乳腺癌风险：孟德尔随机化研究的见解
Arch Dermatol Res. 2024 Oct 10;316(9):671. doi: 10.1007/s00403-024-03435-w.
引用本文的文献
1
IL17 in Sarcoidosis - A level playing field?结节病中的白细胞介素17——公平竞争环境？
Sarcoidosis Vasc Diffuse Lung Dis. 2025 Jun 25;42(2):16288. doi: 10.36141/svdld.v42i2.16288.
2
Use of Mendelian randomization to assess the causal status of modifiable exposures for rheumatic diseases.利用孟德尔随机化评估风湿性疾病可改变暴露因素的因果关系。
Best Pract Res Clin Rheumatol. 2024 Dec;38(4):101967. doi: 10.1016/j.berh.2024.101967. Epub 2024 Jun 30.
本文引用的文献
1
A double-blind, placebo-controlled, randomized withdrawal trial of sarilumab for the treatment of glucocorticoid-dependent sarcoidosis.一项关于沙瑞鲁单抗治疗糖皮质激素依赖型结节病的双盲、安慰剂对照、随机撤药试验。
Rheumatology (Oxford). 2024 May 2;63(5):1297-1304. doi: 10.1093/rheumatology/kead373.
2
Genetically proxied TYK2 inhibition is associated with reduced sarcoidosis susceptibility.基因代理的酪氨酸激酶2（TYK2）抑制与结节病易感性降低相关。
Ann Rheum Dis. 2023 Mar;82(3):445-446. doi: 10.1136/ard-2022-223513. Epub 2022 Dec 9.
3
Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial.托珠单抗治疗糖皮质激素治疗的活动性多发性肌痛患者的疾病活动度：一项随机临床试验。
JAMA. 2022 Sep 20;328(11):1053-1062. doi: 10.1001/jama.2022.15459.
4
Genetically proxied IL-6 receptor inhibition and risk of polymyalgia rheumatica.基因代理的白细胞介素-6受体抑制与风湿性多肌痛风险
Ann Rheum Dis. 2022 Sep 12;81(10):1480-1482. doi: 10.1136/annrheumdis-2022-222578.
5
Genetically Downregulated Interleukin-6 Signaling Is Associated With a Favorable Cardiometabolic Profile: A Phenome-Wide Association Study.基因下调的白细胞介素-6信号传导与良好的心脏代谢特征相关：一项全表型关联研究。
Circulation. 2021 Mar 16;143(11):1177-1180. doi: 10.1161/CIRCULATIONAHA.120.052604. Epub 2021 Mar 15.
6
Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents.托珠单抗用于对类固醇节省疗法和抗TNF药物治疗无效的结节病患者。
Respir Med X. 2019;1. doi: 10.1016/j.yrmex.2019.100004. Epub 2019 Feb 21.
7
Sarcoidosis induced by tocilizumab: a paradoxical event?托珠单抗诱发的结节病：一个矛盾的事件？
J Rheumatol. 2013 Oct;40(10):1773-4. doi: 10.3899/jrheum.130278.
8
Increased IL-6 and IL-8 in bronchoalveolar lavage fluids (BALF) from patients with sarcoidosis: correlation with the clinical parameters.结节病患者支气管肺泡灌洗液（BALF）中白细胞介素-6（IL-6）和白细胞介素-8（IL-8）升高：与临床参数的相关性
Clin Exp Immunol. 1997 Jan;107(1):175-81. doi: 10.1046/j.1365-2249.1997.d01-905.x.
Zotero 插件